Filing Overview
Flora Growth Corp. filed a Form 8-K on August 25, 2023 under Item 8.01 and Item 9.01(d). The filing relates to Flora’s planned Form S-3 registration statement and provides access to unaudited pro forma financial information reflecting its acquisition of Franchise Global Health Inc., completed on December 23, 2022.
The supplied filing text identifies the registrant as Flora Growth Corp., not Zerostack Corp. The pro forma statement is presented as of December 31, 2022, assuming the acquisition occurred on January 1, 2022.
Financial Information
- The filing includes an unaudited Pro Forma Consolidated Statement of Loss and Comprehensive Loss and related notes as Exhibit 99.1.
- The supplied text does not include the exhibit’s financial figures; therefore, revenue, profit or loss, cash flow, margins, debt, liquidity, and other quantitative metrics cannot be determined from the provided content.
- The pro forma information is for informational purposes only and is not presented as a projection of Flora’s future financial position or operating results.
Material Changes and Transaction Context
- The principal transaction referenced is Flora’s acquisition of all issued and outstanding common shares of Franchise Global Health Inc., completed December 23, 2022.
- The pro forma presentation is intended to show the effect of the acquisition for the full 2022 period, rather than only from the closing date.
- No new acquisition terms, purchase price, financing details, operating results, or balance-sheet changes are provided in the filing text.
Guidance, Risks, and Unusual Items
- No management guidance or operating outlook is provided.
- The filing expressly cautions that the pro forma information does not project future financial position or operating results.
- No specific contingencies, legal matters, liquidity risks, or unusual items are described in the supplied text.
Investor Verification Checklist
- Review Exhibit 99.1 for the actual pro forma revenue, expenses, net loss, comprehensive loss, and acquisition adjustments.
- Verify the assumptions and accounting treatment used to present the acquisition as occurring on January 1, 2022.
- Assess Flora’s latest reported cash, debt, liquidity, and post-acquisition operating results in its periodic filings.
- Confirm the discrepancy between the requested company name, Zerostack Corp., and the registrant named in the filing, Flora Growth Corp.